These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30838636)

  • 1. Why is pancreatic cancer so deadly? The pathologist's view.
    Hruban RH; Gaida MM; Thompson E; Hong SM; Noë M; Brosens LA; Jongepier M; Offerhaus GJA; Wood LD
    J Pathol; 2019 Jun; 248(2):131-141. PubMed ID: 30838636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion.
    Hong SM; Jung D; Kiemen A; Gaida MM; Yoshizawa T; Braxton AM; Noë M; Lionheart G; Oshima K; Thompson ED; Burkhart R; Wu PH; Wirtz D; Hruban RH; Wood LD
    Mod Pathol; 2020 Apr; 33(4):639-647. PubMed ID: 31700162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
    Yang J; Jiang Y; He R; Liu W; Yang M; Tao L; Fu X; Shen Y; Li J; Liu D; Huo Y; Zhang J; Hua R; Zhang Z; Sun Y
    J Immunol Res; 2019; 2019():8656282. PubMed ID: 31583260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
    Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
    Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lymphatic system and pancreatic cancer.
    Fink DM; Steele MM; Hollingsworth MA
    Cancer Lett; 2016 Oct; 381(1):217-36. PubMed ID: 26742462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symphony in chaos: Immune orchestra during pancreatic cancer progression.
    Sharma P; Jain T; Sethi V; Dudeja V
    EBioMedicine; 2020 Jun; 56():102787. PubMed ID: 32454409
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of MUC13 in pancreatic ductal adenocarcinoma.
    Khan S; Zafar N; Khan SS; Setua S; Behrman SW; Stiles ZE; Yallapu MM; Sahay P; Ghimire H; Ise T; Nagata S; Wang L; Wan JY; Pradhan P; Jaggi M; Chauhan SC
    HPB (Oxford); 2018 Jun; 20(6):563-572. PubMed ID: 29352660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIC1 attenuates invasion and metastasis by inhibiting the IL-6/STAT3 signalling pathway in human pancreatic cancer.
    Hu B; Zhang K; Li S; Li H; Yan Z; Huang L; Wu J; Han X; Jiang W; Mulatibieke T; Zheng L; Wan R; Wang X; Hu G
    Cancer Lett; 2016 Jul; 376(2):387-98. PubMed ID: 27085461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
    Liu QH; Shi ML; Bai J; Zheng JN
    Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
    Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
    Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma.
    Luchini C; Pea A; Lionheart G; Mafficini A; Nottegar A; Veronese N; Chianchiano P; Brosens LA; Noë M; Offerhaus GJA; Yonescu R; Ning Y; Malleo G; Riva G; Piccoli P; Cataldo I; Capelli P; Zamboni G; Scarpa A; Wood LD
    J Pathol; 2017 Oct; 243(2):148-154. PubMed ID: 28722124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
    Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
    Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt2 protein plays a role in the progression of pancreatic cancer promoted by pancreatic stellate cells.
    Xu Y; Li H; Huang C; Zhao T; Zhang H; Zheng C; Ren H; Hao J
    Med Oncol; 2015 Apr; 32(4):97. PubMed ID: 25731618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
    Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
    Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.